Repligen and Cure Autism Now Form Research Funding Partnership to Develop Assessment Tools for Clinical Trials of Autism Therapies | Feb. 27, 2001 #AutisticHistory

[Note: Shared for #AutisticHistory archive purposes. This is NOT An Autistic Ally.]

Repligen and Cure Autism Now Form Research Funding Partnership to Develop Assessment Tools for Clinical Trials of Autism Therapies

NEEDHAM, Mass., Feb. 27 /PRNewswire/ 

Repligen Corporation (Nasdaq: RGEN) and Cure Autism Now announced today that they will collaborate to jointly fund research to develop new tools to measure changes in the symptoms of autism in clinical trials.  Cure Autism Now is a leading private funding organization for autism research.  Research projects eligible for funding will include the development of psychometric tools to measure changes in the social and communicative aspects of autism and methods to quantify changes in the neurophysiological deficits and other neurobehavioral abnormalities characteristic of autism.  The research will be carried through a series of grant awards to academic centers with established expertise in psychometrics or neurophysiology.  The program will be administered by Cure Autism Now and will be initiated with an open Request for Proposals.

The validation of any therapy or other intervention for autism requires assessment of symptom reduction in controlled clinical trials.  Existing tools for autism assessment were primarily developed for the diagnosis of autism and are not optimally sensitive to assess changes in symptoms as a result of therapeutic interventions. 

“We are pleased to join Cure Autism Now in this unique research collaboration,” stated Walter C. Herlihy, President and CEO of Repligen.   “The development of improved methods to quantitatively assess the symptoms of autism will facilitate the clinical evaluation of new therapies.” 

“This project is an important step to insure that we can quickly translate research observations into clinical trials,” stated Portia Iversen, co-founder of Cure Autism Now.  “We need new methods to assess patient improvements as a result of a therapeutic, dietary or behavioral interventions.” 

Repligen Corporation develops new drugs for debilitating pediatric disorders including autism, cancer, immune and metabolic disorders.  Repligen also manufactures and markets a set of patented products based on Protein A, which are used by the pharmaceutical industry to produce therapeutic antibodies.   Its corporate headquarters are located at 117 Fourth Avenue, Needham MA, 02494.  Additional information may be requested from 

Cure Autism Now is an organization of parents, physicians, and researchers, dedicated to promoting and funding research with direct clinical implications for treatment and a cure for autism.  The largest private funder of autism research, since its founding in 1995 Cure Autism Now has directed over $5 million to support research projects and a crucial scientific resource – the Autism Genetic Resource Exchange (AGRE).  AGRE is the world’s first collaborative gene bank that contains information on families with more than one child with autism.  Additional information about Cure Autism Now can be found at 

This press release contains forward-looking statements based on current management expectations.  There are certain key factors which could cause future results to differ materially from those anticipated by management. Such factors include, but are not limited to: uncertainty in the realization of future revenues, the uncertain timelines for clinical activity, required regulatory approvals, results of pending or future clinical trials, Repligen’s ability to continue to establish collaborative arrangements with third parties; the Repligen’s ability to maintain financial stability; the technical risks associated with development and manufacture of clinical products; the fact that there can be no assurances that patents relating to the Repligen’s potential products will afford adequate protection to   Repligen, the risks of technological change and competition, and the competitive environment of the biotechnology and pharmaceutical industries.   These factors are more fully discussed in Repligen’s periodic filings with the Securities and Exchange Commission.

More With Cure Autism Now

Cure Autism Now: POLITICAL ACTION ALERT | May 13, 2001

POLITICAL ACTION ALERT – Sunday, May 13, 2001 We need the immediate help of everyone in the developmentally disabled community! A group of families have recently begun an effort to get some tax relief for the more than three million families in the US who have children with developmental disabilities. The basic idea is to…

Cure Autism Now: Antibiotics for Autism | December 2000

Antibiotics for Autism Ivanhoe Broadcast News December 2000 Antibiotics for Autism Antibiotics for AutismTelevision News Service/Medical BreakthroughsIvanhoe Broadcast News, Inc. December 2000 (Ivanhoe Newswire) — According to the National Institute of Mental Health, about 1 in every 500 people has autism — a developmental disorder that affects language and social skills. For years it’s been largely…

Cure Autism Now Parent Advisory Board as of June 1996

The CAN Parent Advisory Board The CAN international parent board will monitor research efforts from around the world, circulate the latest findings among the scientific work group, and coordinate fundraising. CAN believes that it is the interaction between concerned parents and researchers in the field that will help keep motivation high and the pace of…


Something went wrong. Please refresh the page and/or try again.


Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid. 

ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.

The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t workIn study after repeated study: ABA (conversion therapy) doesn’t work. 

What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.

The ‘cure’ for Autistics not born yet is the prevention of birth. 

The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome. 

This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.

Fact: You can’t cure Autistics from being Autistic.

Fact: You can’t recover an Autistic from being Autistic.

Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.

[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]

Fact: Vaccines Do Not Cause Autism.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: